Royal Bank of Canada
STLN

Royal Bank of Canada’s Starling Oncology STLN Stock Holding History

Royal Bank of Canada’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
23,327
+1,070
+5% +$4.5K ﹤0.01% 5261
2026
Q1 		$68K Buy
22,257
+17,151
+336% +$52.6K ﹤0.01% 5338
2025
Q4 		$18K Buy
5,106
+3,568
+232% +$13.2K ﹤0.01% 6122
2025
Q3 		$5K Sell
1,538
-30,606
-95% -$105K ﹤0.01% 6715
2025
Q2 		$66K Buy
+32,144
New +$80.4K ﹤0.01% 5798
2024
Q3 		– Sell
-130
Closed – – 7441
2024
Q2 		$0 Buy
130
+75
+136% +$64 ﹤0.01% 7535
2024
Q1 		$0 Sell
55
-978
-95% -$1.86K ﹤0.01% 7594
2023
Q4 		$2K Sell
1,033
-6,837
-87% -$11.9K ﹤0.01% 6842
2023
Q3 		$11K Buy
7,870
+108
+1% +$112 ﹤0.01% 6398
2023
Q2 		$4K Buy
7,762
+5,753
+286% +$3.04K ﹤0.01% 6751
2023
Q1 		$1K Sell
2,009
-3,969
-66% -$5.06K ﹤0.01% 6938
2022
Q4 		$10K Buy
5,978
+5,376
+893% +$15.1K ﹤0.01% 6554
2022
Q3 		$3K Buy
602
+496
+468% +$2.92K ﹤0.01% 6928
2022
Q2 		$1K Sell
106
-473
-82% -$3.44K ﹤0.01% 7209
2022
Q1 		$4K Buy
+579
New +$3.91K ﹤0.01% 7339
2021
Q4 		– Sell
-2,580
Closed -$26K – 7894
2021
Q3 		$26K Buy
2,580
+80
+3% +$794 ﹤0.01% 6555
2021
Q2 		$25K Hold
2,500
– – ﹤0.01% 6452
2021
Q1 		$25K Buy
2,500
+2,200
+733% +$23.4K ﹤0.01% 6305
2020
Q4 		$3K Hold
300
– – ﹤0.01% 6810
2020
Q3 		$3K Hold
300
– – ﹤0.01% 6262
2020
Q2 		$3K Buy
+300
New +$2.98K ﹤0.01% 6214

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada's STLN Position: Q2 2026 in Review

Royal Bank of Canada increased its Starling Oncology (STLN) stake by 4.8% in Q2 2026, buying an estimated $4.5K and bringing the position to 23,327 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #5261.

Royal Bank of Canada first reported a position in STLN in Q2 2020 and has held it in 21 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Royal Bank of Canada held 23,327 shares of Starling Oncology worth $128K as of Q2 2026.
  • Royal Bank of Canada bought 1,070 Starling Oncology shares in Q2 2026, an estimated $4.5K.
  • Starling Oncology made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5261 holding.
  • Royal Bank of Canada first reported a position in Starling Oncology in Q2 2020 and has held it in 21 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.